SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : InterMune (nasdaq)ITMN -- Ignore unavailable to you. Want to Upgrade?


To: IRWIN JAMES FRANKEL who wrote (209)4/8/2002 6:12:11 PM
From: quidditch  Respond to of 508
 
IJ, "...negative interpretation from some RMC investigators who had reviewed the [ITMN] study of the effects of actimmune..."--interpretation distilled from reviewing someone else's study--for me that is a meta-study. <g>

That the study was not an ITMN study may well be correct--I recalled (incorrectly) that the study was under ITMN aegus.

quid